Delivery Order SPE2DB20D1100-SPE2DB24FD1Q1

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $35K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,024.40 firm fixed-price delivery order is for the provision of REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $23,954.18 and covers the delivery of Remicade 100 mg vials. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,012.20, is for the delivery of REMICADE 100 MG VIALS medical supplies. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is also the holder of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Remicade 100 mg vials, a prescription medication, with a ceiling value of $2,294.25 and a performance period ending on June 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Remicade (infliximab) 100 mg vials. The contract has a ceiling value of $5,582.95 and a period of performance through July 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,032.35, is for the supply of REMICADE 100 MG VIALS, a specialty medication. The contract is a Firm Fixed Price (FFP) type and has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REMICADE 100 MG VIALS. The contract has a ceiling value of $26,077.82 and is a firm fixed-price delivery order. It is not set aside for any special consideration. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,094.36 firm fixed-price delivery order is for the supply of REMICADE 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $24,787.38 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 100 mg vials of the pharmaceutical product Remicade. The contract has an ultimate completion date of September 5, 2024. AmerisourceBergen is one of the largest pharmaceutical distributors in the United States and has been awarded numerous federal contracts to provide a wide range of pharmaceutical and medical supplies to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,857.41 firm fixed-price delivery order is for the supply of REMICADE 100 MG VIALS, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp is also the holder of a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD1Q1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REMICADE 100 MG VIALS. The contract has a ceiling value of $35,458.10 and is a firm fixed price delivery order that runs through August 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This specific delivery order is not set aside and is part of the company's broader federal contracting activities to provide essential pharmaceutical and medical supplies to various government agencies and healthcare programs.

Generated 11/6/24, 9:12 AM